Recent developments include: April 2024: Geistlich Pharma AG acquired Bionnovation Biomedical in Brazil to expand its bone graft substitutes business in Latin America., June 2023: Geistlich Pharma AG launched a non-surgical periodontitis treatment gel. It is a combination of hyaluronic acid, a thermosensitive filler to promote healing., January 2023: Envista launched creos syntogain, a biomimetic bone graft substitute in two granule sizes (0.2-1.0 mm and 1.0-2.0 mm)., July 2022: botiss biomaterials GmbH and the International Team for Implantology (ITI) collaborated to offer training to the clinicians for the treatment concepts in the field of oral tissue regeneration., March 2022: CGbio, a company specializing in regenerative medicine, collaborated with Kerunxi Medical to export Bongros Dental, a bone graft material including synthetic bone graft., October 2021: CoreBone received USD 3.7 million funding from the Guangzhou Sino-Israel Biotech Investment Fund ("GIBF"), which specializes in bringing Israeli medical technologies to the Chinese Market. CoreBone is a company that offers bioactive bone graft materials used in orthopedic and dental treatments., January 2021: Dentsply Sirona acquired Datum Dental, Ltd. with its strong OSSIX biomaterial portfolio. The portfolio includes various regenerative products, including bone graft substitutes.. Key drivers for this market are: Introduction of Advanced Bone Graft Substitutes to Propel Market Growth. Potential restraints include: Introduction of Advanced Bone Graft Substitutes to Propel Market Growth. Notable trends are: Introduction of Advanced Bone Graft Substitutes to Propel Market Growth.

Synthetic bone grafts are biocompatible materials that mimic the structure and function of natural bone. They are typically made from bioceramics, such as hydroxyapatite and tricalcium phosphate, or biomaterials, such as polymers and collagen. Synthetic bone grafts offer several advantages over traditional bone grafts, including reduced risk of disease transmission, lower cost, and improved handling characteristics.Xenografts are bone grafts taken from a different species, typically cows or pigs. They are processed to remove all cellular components, resulting in a biocompatible material that can be used for bone grafting procedures. Xenografts are less expensive than allografts and have a lower risk of disease transmission. Recent developments include: March 2022: With Zimmer Biomet, Biocomposites has a contract to distribute the brand-new Genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of extraordinary purity that was created to achieve the ideal balance between osteoconductive scaffold strength and persistence in the body for bone architecture remodeling., March 2022: For the export of Bongros Dental, a bone graft substance, CGbio signed a five-year contract worth KRW 10 billion with Kerunxi Medical, a Chinese company specializing in dental equipment.. Notable trends are: Growing advanced surgical techniques to boost market growth.

The market offers a range of BMP products, including recombinant human BMPs (rhBMPs) and naturalBMPs. Recombinant BMPs are produced using genetic engineering techniques and offer advantages such as higher purity and consistent potency. Natural BMPs are derived from animal or human tissues and are often used in combination with other bone grafting materials. Recent developments include: August 2022: Orthofix Medical Inc. formed a strategic partnership with CGBio to advance the clinical development and commercialization of Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials and other forthcoming tissue regenerative solutions within the United States and Canadian markets., September 2019: FDA approval was granted to Medtronic for the utilization of Infuse bone graft, enabling its application in Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. Notable trends are: Incidences of sports-related injuries, the growing demand for minimally invasive surgeries, and technological advancements are driving the market growth..